Skip to main content

. 1976 Nov 6;2(6044):1109–1110. doi: 10.1136/bmj.2.6044.1109

A black thyroid and minocycline treatment.

H D Attwood, X Dennett

PMCID: PMC1689400 PMID: 990789

1109

Images in this article

Figs a-b
on p.1109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Benitz K. F., Roberts G. K., Yusa A. Morphologic effects of minocycline in laboratory animals. Toxicol Appl Pharmacol. 1967 Jul;11(1):150–170. doi: 10.1016/0041-008x(67)90035-x. [DOI] [PubMed] [Google Scholar]
Borel D. M., Reddy J. K. Excessive lipofuscin accumulation in the thyroid gland in mucoviscidosis. Arch Pathol. 1973 Oct;96(4):269–271. [PubMed] [Google Scholar]
Kelly R. G., Kanegis L. A. Metabolism and tissue distribution of radioisotopically labelled minocycline. Toxicol Appl Pharmacol. 1967 Jul;11(1):171–183. doi: 10.1016/0041-008x(67)90036-1. [DOI] [PubMed] [Google Scholar]
Ryan G. B., Anderson M., Menkes J. H., Dennett X. Lipofuscin (ceroid) storage disease of the brain neuropathological and neurochemical studies. Brain. 1970;93(3):617–628. doi: 10.1093/brain/93.3.617. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES